Brazil has approved legislation permitting pharmacies to operate within supermarkets, expanding consumer access to OTC medicines while maintaining strict pharmacist oversight and existing safety standards.
Futura Medical is seeking OTC medical device approval for ED treatment Eroxon Intense, designed for men who prefer a stronger sensation to the original Eroxon product.
“Four or five major acquisitions over the last few years repositioned it, a 140-year-old company, from being a B-to-B company to B-to B-to-C company. That is a major enterprise strategy shift,” says CEO Patrick Lockwood-Taylor.
“In a very siloed organization made up of a jigsaw of different companies, no one was thinking enterprise first,” says Perrigo CEO Patrick Lockwood-Taylor. “The fundamentals of running operations, brand-building, innovation, they are now as they were.”
Stada is reviewing potential M&A for its Consumer Healthcare business, which last year grew its sales despite a weak cough & cold season.
At opening session of CHPA’s annual Self-Care Leadership Summit on March 17 in Orlando, it presented Fuad Sawaya its highest honor named for Ivan Combe, an industry pioneer who served on its board from 1958 until 2000.
Haleon is making health literacy a core growth and sustainability pillar, aiming by 2030 to help more than 300m people a year take control of their everyday health through system‑level policy engagement, community programmes and improved access to self‑care products.
In a foreword to a blog post by PAGB CEO Michelle Riddalls, the UK medicines regulator MHRA has signalled strong support for expanding Rx‑to‑OTC reclassification as a safe way to ease pressure on the NHS, strengthen the role of pharmacists and improve access to medicines.
A new oral health manufacturing site in Shanghai will help facilitate Haleon's push into China's tier 2 and 3 cities where the middle class population is rapidly expanding.
AHPA Awards Hero, Champion, Visionary and others at annual meeting; Kimberly-Clark’s information chief has major-merger experience; RäFoods’ marketing chief has history with CEO; and Eshbal adds VP for North America expansion.
Distribution deals helped Galenica grow its OTC sales in 2025 despite lower demand for cold and flu products.
A round-up of the latest European health & wellness people moves: Aboca hires Germany head; SkinBioTherapeutics gets interim CEO; Reckitt adds experience to board.
Avia Pharma has acquired fellow Swedish firm Allderma to add to its offering brands like Hårkontrol, Daxxin and Lactiplus.
Higher sales of dietary supplements in key markets like the US and China helped Reckitt's Self-Care business to grow in 2025 despite a weak cold & flu season.
Bayer Consumer Health will lean on its "road to billions" strategy to achieve growth in 2026 against a volatile market backdrop.
The global consumer health industry sees emerging markets as an engine for growth in an otherwise stagnating market. But panelists at the Global Self-Care Forum in Geneva warned that regulatory gaps and lack of harmonization may stunt this potential in the short term.
A round up of the latest health and wellness moves: Angelini Pharma names digital chief; SFI Health changes CEO; Nestlé adds experience to board.
In this episode of HBW Insight’s Over the Counter podcast, we speak with probiotic expert David Pineda Ereño about Europe’s fragmented regulatory landscape, the future of the “probiotic” definition, and how companies can navigate diverging EU Member State positions.
Through deal with Dr Reddy's, Singapore's Zuellig will commercialize Nicotinell NRT products in South Korea.
“Infant formula has consumed cash” and “at the end of the day, we need to be committed to improve our cash flow,” says CFO Eduardo Bezerra as Perrigo continues reviewing it options for the business.